SCHEMBL13844015

SCHEMBL13844015

CCN(c1nccs1)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 2/20 0.35
FBP1 P09467 2/20 0.35
HTR7 P34969 1/20 0.33
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
ALDH1A1 P00352 2/20 0.32
TSHR P16473 1/20 0.32
NOS1 P29475 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP3A4 P08684 1/20 0.31
LATS1 O95835 1/20 0.31
LATS2 Q9NRM7 1/20 0.31
PDK1 Q15118 1/20 0.30
LMNA P02545 1/20 0.30
XBP1 P17861 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14099272 0.76 SCN1A (0.40) FFAR2SCN1ASCN2ASCN3ATSHR
SCHEMBL4722623 0.75 SCN1A (0.43) FFAR2FBP1HTR7SCN1ASCN2A
SCHEMBL14099264 0.74 SCN1A (0.42) FFAR2FBP1HTR7SCN1ASCN2A
SCHEMBL173416 0.74
SCHEMBL19997269 0.72 FFAR2 (0.37) FFAR2FBP1HTR7SCN1ASCN2A
SCHEMBL2226558 0.72
SCHEMBL14099274 0.70 MEN1 (0.44) ALDH1A1TSHRHSD17B10LMNA
SCHEMBL4720415 0.69 SCN1A (0.42) FFAR2FBP1HTR7SCN1ASCN2A
SCHEMBL13844014 0.69 TSHR (0.43) FBP1TSHR
SCHEMBL12873564 0.69 TAAR1 (0.36) TSHRLATS1LATS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7528163-B2 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye MERCK & CO. INC. (US) 2009-05-05 US disclosed
US-7414067-B2 Ophthalmic compositions for treating ocular hypertension MERCK & CO. INC. (US) 2008-08-19 US disclosed